| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |